Related Experiment Video
Updated: Jul 15, 2026
07:45
Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
Published on: January 23, 2019
Henoch-Schönlein purpura: recent advances
1Nephro-Urology Unit, Institute of Child Health, University College London, London, UK. m.dillon@ich.ucl.ac.uk
Clinical and Experimental Rheumatology
|April 13, 2007
Summary
Recent Henoch-Schönlein purpura (HSP) research includes new classification criteria, genetic factors influencing complications, and steroid treatment effectiveness. Prophylactic steroids do not prevent complications but aid in their treatment.
Area of Science:
- Pediatrics
- Rheumatology
- Immunology
Background:
- Henoch-Schönlein purpura (HSP) is a common childhood vasculitis.
- Understanding HSP's classification, genetic basis, and treatment is crucial for patient outcomes.
Purpose of the Study:
- To summarize recent advancements in Henoch-Schönlein purpura research.
- To highlight new classification criteria, genetic insights, and therapeutic evidence for HSP.
Main Methods:
- Review of recent literature on childhood vasculitis and HSP.
- Analysis of proposed classification criteria and genetic polymorphism studies.
- Evaluation of evidence regarding steroid use in HSP management.
Main Results:
- A new classification for childhood vasculitides, including HSP, has been proposed.
- Genetic polymorphisms associated with HSP predisposition or protection have been identified.
- Early steroid administration does not prevent HSP complications but can treat existing ones.
Conclusions:
- Updated classification systems are refining the diagnosis of HSP.
- Genetic research offers potential insights into HSP pathogenesis and risk.
- Steroid therapy has a defined role in managing HSP complications, not prevention.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...